Lipophilicity characterization of new N-phenylamino-azaspiranes as potential anticonvulsant agents

Biomedical Chromatography

Volumn 20, Issue 11, 2006, Pages 1185-1191

  Obniska, Jolanta ^a   Kamiński, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Anticonvulsant activity; Lipophilicity; N phenylamino 2 azazpiro 4.4 nonane and 4.5 decane 1,3 dione; RPTLC

Indexed keywords

PARAFFINS; PROPANOL;

ANTICONVULSANT ACTIVITY; AZASPIRANE; BUFFER PH; LIPOPHILICITY; MOBILE PHASIS; N-PHENYLAMINO-2-AZAZPIRO[4.4]NONANE- AND [4.5]DECANE-1,3-DIONE; N-PROPANOL; REVERSED-PHASE THIN-LAYER CHROMATOGRAPHY; RPTLC; TRIS BUFFERS;

THIN LAYER CHROMATOGRAPHY;

ANTICONVULSIVE AGENT; BUFFER; N PHENYLAMINO 2 AZASPIRO[4.4]NONANE 1,3 DIONE DERIVATIVE; N PHENYLAMINO 2 AZASPIRO[4.5]DECANE 1,3 DIONE DERIVATIVE; N PHENYLAMINO AZASPIRANE DERIVATIVE; PROPANOL; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONCENTRATION RESPONSE; CORRELATION FUNCTION; DRUG DESIGN; DRUG DETERMINATION; DRUG SYNTHESIS; LIPOPHILICITY; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; STRUCTURE ACTIVITY RELATION; THIN LAYER CHROMATOGRAPHY;

EID: 33751096967     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.682     Document Type: Article

References (18)

1. Cimpan G, Hadaruga M and Miclaus V. Lipophilicity characterization by reversed-phase liquid chromatography of some furan derivatives. Journal of Chromatography A 2000; 869: 49-55.
2. MW by reversed-phase thin-layer chromatography. Journal of Chromatography A 1994; 673: 113.
3. Eros D, Kövesdi I, Orfi L, Takács-Novák, Acsády G and Kéri G. Reliability of logP predictions based on calculated molecular descriptors: a critical review. Current Medical Chemistry 2002; 9: 1819-1829.
4. Hollósy F, Lóránd T, Örfi L, Erös D, Kéri G and Idei M. Relationship between lipophilicity and antitumor activity of molecule library of Mannich ketones determined by high-performance liquid chromatography, clogP calculation and cytotoxicity test. Journal of Chromatography B 2002; 768: 361-368.
5. Kamifiski K, Obniska J, Zagórska A and Maciag D. Synthesis, physicochemical and anticonvulsant properties of new N-(pyridine-2-yl) derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Part II. Archiv der Pharmazie-Chemistry in Life Science 2006; 339(5): 255-261.
6. Kerns EH, Di L, Petusky S, Kleintop T, Huryn D, McConnell O and Carter G. Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography-mass spectroscopy. Journal of Chromatography A 2003; 791- 381-382.
7. Kostecka M, Niewiadomy A and Czeczko R. Evaluation of N-substituted 2,4-dihydroxphenylthioamide fungicide lipophilicity using the chromatographic techniques HPLC and HPTLC. Chromatographia 2005; 62: 121-126.
8. Kupferberg HJ. Antiepileptic Drug Development Program: a cooperative effort of government and industry. Epilepsia 1989; 30 (suppl.): 51-56.
9. Obniska J. Synthesis and anticonvulsant activity of a series of N-substituted 2-azaspiro[4.5]decane-1,3-diones and 8-phenyl-2-azaspiro[4.5]decane-1,3-diones. Acta Poloniae Pharmaceutica - Drug Research 2004; 61: 467-472.
10. Obniska J and Kamiński K. RPTLC determination of the lipophilicity of some new N-[(4-arylpiperazin-1-yl)alkyl] spirosuccinimides. Journal of Planar Chromatography 2005a; 18: 384-387.
11. Obniska J and Kamiński K. Relationships between the lipophilicity and anticonvulsant activity of N-benzyl-2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione derivatives. Journal of Planar Chromatography 2005b; 18: 240-243.
12. Obniska J and Kamiński K. Synthesis and anticonvulsant properties of new N-phenylamino derivatives of 2-azaspiro[4.4]nonane, 2-azaspiro[4.5]decane-1,3-dione and 3-cyclohexyl pyrrohdine-2,5-dione. Part IV. Acta Poloniae Pharmaceutica - Drug Research 2006; 63: 000-000 (in press).
13. Obniska J, Dzierzawska-Majewska A, Zagórska A, Zajdel P and Karolak-Wojciechowska J. Synthesis, physicochemical and anti-convulsant properties of N-benzyl and N-aminophenyl derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Part I. Il Farmaco 2005; 60: 529-539.
14. Obniska J, Kamiński K, Zgórska A, Dzierzawska-Majewska A and Karolak-Wojciechowska J. Synthesis and anticonvulsant activity of new fluorinated N-phenyl- and N-benzyl-2-azaspiro[4.4]nonane-and [4.5]decane-1,3-dione derivatives. Journal of Fluorine Chemistry 2006; 127: 417-425.
15. Perišić-Janjić N, Djaković-Sekulić T, Stojanović S and Penov-Gaši. Evaluation of the lipophilicity of some dehydroepiandrosterone derivatives using RP-18 HPTLC chromatography. Chromatographia 2004; 60: S201.
16. Sârbu C, Casoni D, Darabantu M and Maiereanu C. Quantitative structure-retention and retention-activity relationships of some 1,3-oxazolidine systems by RP-HPTLC and PCA. Journal of Pharmacy and Biomedical Analysis 2004; 35: 213-214.
17. Sławik T and Kowalski C. Lipophilicity of a series of 1,2-benzisothiazol-3(2H)-ones determined by reversed-phase thin-layer chromatography. Journal of Chromatography A 2002; 952: 295-299.
18. Takács-Novák K, Perjési P and Vámos J. Determination of logP for biologically active chalcones and cyclic chalcone analogues by RP-TLC. Journal of Planar Chromatography 2001; 14: 42.